Keyphrases
Abruptio Placentae
42%
Adverse Outcomes
100%
Adverse Pregnancy Outcomes
14%
Alpha-fetoprotein
100%
Antenatal Surveillance
14%
Canada
14%
Chromosomal Abnormalities
14%
Confounding Factors
14%
Fetal Death
28%
Fetal Growth Restriction
14%
High Risk
71%
Human Chorionic Gonadotropin
100%
Logistic Regression
14%
Low-risk Women
57%
Marker Screening
14%
Maternal Serum
100%
Maternal Serum alpha-fetoprotein (MSAFP)
85%
Nova Scotia
14%
Obstetric Complications
14%
Pre-pregnancy
28%
Preeclampsia
14%
Pregnancy Complications
14%
Pregnant Women
14%
Preterm Birth
14%
Relative Risk
42%
Risk Status
28%
Screening Value
14%
Serological Screening
14%
Structural Anomalies
14%
Women-only
14%
Medicine and Dentistry
Adverse Outcome
100%
Chorionic Gonadotropin
100%
Chromosome Aberration
14%
Fetoprotein
100%
Fetus Death
28%
Fetus Growth
14%
Logistic Regression Analysis
14%
Maternal Serum
100%
Obstetric Complication
14%
Obstetrics
14%
Pre-Eclampsia
14%
Pregnancy Complication
14%
Premature Labor
14%
Solutio Placentae
42%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Outcome
100%
Agrotis
14%
Chorionic Gonadotropin
100%
Chromosome Aberration
14%
Fetoprotein
100%
Fetus Death
28%
Preeclampsia
14%
Pregnancy Complication
14%
Premature Labor
14%
Solutio Placentae
42%